Literature DB >> 21596728

Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis.

Hajer Elkout1, Peter J Helms, Colin R Simpson, James S McLay.   

Abstract

BACKGROUND: Little is known about the impact of British asthma management guideline revisions. Concerns about the use of high dose inhaled corticosteroids (ICS) in children have resulted in the promotion of add-on therapy. AIMS: To assess prescribing patterns of asthma medication in children in the primary care setting.
METHODS: Retrospective observational study of asthma prescribing in children aged 0-18 years using primary care database from 2001 to 2006.
RESULTS: The proportion of children prescribed oral corticosteroids increased significantly (from 6% in 2001-2002 to 16% in 2005-2006, p<0.001), while the proportion of children prescribed an ICS dose of >400 mcg decreased from 16.2% to 11.7% (P<0.001). The proportion of children prescribed an add-on therapy and an ICS dose >400 µg, increased from 38.8 % in 2001-2002 to 61.2% in 2005-2006 (p<0.001).
CONCLUSIONS: Although adherence with asthma management guidelines is not optimal, this study has identified improved adherence in primary care.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596728     DOI: 10.1136/adc.2010.206268

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Cost considerations of therapeutic options for children with asthma.

Authors:  Sandra Chuang; Adam Jaffe
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

2.  Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea.

Authors:  Min Sook Seo; Jodie Hillen; Dong Yoon Kang; Nicole Pratt; Ju-Young Shin
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

3.  Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new users.

Authors:  Marina Bianchi; Antonio Clavenna; Marco Sequi; Angela Bortolotti; Ida Fortino; Luca Merlino; Maurizio Bonati
Journal:  BMC Pulm Med       Date:  2011-10-17       Impact factor: 3.317

4.  Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study.

Authors:  Steve W Turner; Kathryn Richardson; Annie Burden; Mike Thomas; Clare Murray; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2015-06-11       Impact factor: 2.871

5.  Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.

Authors:  Marietta Rottenkolber; Rainald Fischer; Luisa Ibáñez; Joan Fortuny; Robert Reynolds; Justyna Amelio; Roman Gerlach; Martin Tauscher; Petra Thürmann; Joerg Hasford; Sven Schmiedl
Journal:  BMC Pulm Med       Date:  2015-05-06       Impact factor: 3.317

6.  Utilisation and off-label prescriptions of respiratory drugs in children.

Authors:  Sven Schmiedl; Rainald Fischer; Luisa Ibáñez; Joan Fortuny; Olaf H Klungel; Robert Reynolds; Roman Gerlach; Martin Tauscher; Petra Thürmann; Joerg Hasford; Marietta Rottenkolber
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

7.  Real-life prescribing of asthmatic treatments in UK general practice over time using 2014 BTS/SIGN steps.

Authors:  Alicia Gayle; Abigail Tebboth; Marie Pang; Florent Guelfucci; Ramzi Argoubi; Steven Sherman; Vincent Mak
Journal:  NPJ Prim Care Respir Med       Date:  2019-07-11       Impact factor: 2.871

8.  The PIPc Study-application of indicators of potentially inappropriate prescribing in children (PIPc) to a national prescribing database in Ireland: a cross-sectional prevalence study.

Authors:  Emma Barry; Frank Moriarty; Fiona Boland; Kathleen Bennett; Susan M Smith
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

9.  Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study.

Authors:  Steve W Turner; Clare Murray; Mike Thomas; Annie Burden; David B Price
Journal:  NPJ Prim Care Respir Med       Date:  2018-07-23       Impact factor: 2.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.